Cat.#: ACPP-1819
| Despition | TRH Human Recombinant |
| SIZE | 100 mg |
| Sequence | Pyr-His-Pro-NH2. |
| Purity | > 99.0% by Analysis by RP-HPLC |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1276 | MAP3K4 Blocking Peptide (AC1276) | 250 µg | inquiry |
| ACPP-1313 | Norepinephrine Transporter Blocking Peptide (AC1313) | 250 µg | inquiry |
| ACPP-1029 | Recombinant Human beta Nerve Growth Factor Protein (AC1029) | 50 µg | inquiry |
| ACPP-1212 | PAX8 Blocking Peptide (AC1212) | 250 µg | inquiry |
| ACPP-1237 | CRMP1 Blocking Peptide (AC1237) | 250 µg | inquiry |
| ACPP-1386 | Human HMGN1 Protein (AC1386) | 2 µg | inquiry |
| ACPP-1010 | Synthetic Nanodisc Human GPR56 Protein (AC1010) | 10 µg | inquiry |
| ACPP-1097 | Synthetic Nanodisc Human ENTPD2 Protein (AC1097) | 10 µg | inquiry |
| ACPP-1516 | Human Insulin Protein, Yeast (AC1516) | 2 mg | inquiry |
| ACPP-1668 | Human BDNF Protein, His (AC1668) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.